Sales & Marketing Sponsored 12 Questions with Steve Sanghera Steve Sanghera is the CEO and co-founder of Inventus.
Sales & Marketing Sponsored 12 Questions with Dermot Kenny Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.
Sales & Marketing Sponsored 12 Questions with Jim Sage Jim Sage is a seasoned global pharmaceutical executive with extensive marketing, commercial, and leadership experience across major therapeutic areas.
R&D Sponsored 12 Questions with Phil Davey Phil Davey is the General Manager at Alnylam for the UK, Ireland, the Nordics, and Canada.
R&D Sponsored 12 Questions With Trenton M. Johnson Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.
Digital Sponsored 12 Questions with Felix Faber Mindpeak's Felix Faber is an award-winning entrepreneur and computer scientist with a track record of founding companies.
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
